Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Molecure S.A.

MOC
Current price
9.6 PLN -0.15 PLN (-1.54%)
Last closed 9.89 PLN
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange Warsaw Stock Exchange
Capitalization 169 342 259 PLN
Yield for 12 month -46.19 %
1Y
3Y
5Y
10Y
15Y
MOC
21.11.2021 - 28.11.2021

Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a chitotriosidase/AMCASE inhibitor that has completed phase I clinical trial for the treatment of sarcoidosis, as well as in preclinical stage to treat idiopathic pulmonary fibrosis and NASH. It also develops OATD-02, an arginase 1 and arginase 2, which is in Phase I clinical trial for the treatment of cancer; USP7, USP21, and YKL-40 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland. Address: Zwirki i Wigury 101, Warsaw, Poland, 02-089

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

114.23 PLN

P/E ratio

Dividend Yield

Current Year

+99 PLN

Last Year

Current Quarter

Last Quarter

Current Year

-1 651 872 PLN

Last Year

-1 640 819 PLN

Current Quarter

-781 103 PLN

Last Quarter

-355 951 PLN

Key Figures MOC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -30 226 808 PLN
Operating Margin TTM -830.35 %
PE Ratio
Return On Assets TTM -15.15 %
PEG Ratio
Return On Equity TTM -25.19 %
Wall Street Target Price 114.23 PLN
Revenue TTM 1 527 570 PLN
Book Value 4.78 PLN
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -46.9 %
Dividend Yield
Gross Profit TTM -21 410 PLN
Earnings per share -1.23 PLN
Diluted Eps TTM -1.23 PLN
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MOC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MOC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation MOC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 999999.9999
Price Sales TTM 110.8573
Enterprise Value EBITDA -12.1876
Price Book MRQ 2.1063

Financials MOC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MOC

For 52 weeks

9.64 PLN 22.59 PLN
50 Day MA 12.24 PLN
Shares Short Prior Month
200 Day MA 15.16 PLN
Short Ratio
Shares Short
Short Percent